Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | C5AR1 | P21730 | 9/20 | 0.33 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | GNRHR | P30968 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4766009 | 1.00 | TACR1 (0.33) | TACR1ADORA2AADORA2BADORA1C5AR1 | |
| SCHEMBL4763444 | 0.91 | MAPT (0.33) | ADORA2AADORA2BADORA1ALDH1A1 | |
| SCHEMBL4763440 | 0.91 | MAPT (0.33) | ADORA2AADORA2BADORA1ALDH1A1 | |
| SCHEMBL4763163 | 0.89 | ADORA2A (0.37) | ADORA2AADORA2BADORA1TAS2R8ALDH1A1 | |
| SCHEMBL4763169 | 0.89 | ADORA2A (0.37) | ADORA2AADORA2BADORA1TAS2R8ALDH1A1 | |
| SCHEMBL4762674 | 0.88 | ADORA2A (0.36) | ADORA2AADORA2BADORA1C5AR1TAS2R8 | |
| SCHEMBL4762676 | 0.88 | ADORA2A (0.36) | ADORA2AADORA2BADORA1C5AR1TAS2R8 | |
| SCHEMBL4891718 | 0.86 | ADORA2B (0.41) | TACR1ADORA2AADORA2BADORA1C5AR1 | |
| SCHEMBL4766007 | 0.84 | C5AR1 (0.41) | ADORA2AADORA2BADORA1C5AR1HSD11B1 | |
| SCHEMBL4771502 | 0.84 | MAPT (0.35) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678181-B1 | A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS INC (US) | 2008-12-31 | — | — | EP | disclosed |